An interventional study of Ultrasound scan in Pneumonia, Pleural Effusion and Renal Colic, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-19.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Diagnostic
This is an interventional multi-centre study comparing two groups of general practitioners with or without an ultrasound scanner over a period of 6 months. The evaluation focuses on the management of patients for 8 pathologies:
The secondary hypotheses are:
1,564 studies on the registry are indexed under Pneumonia; 265 are open to participants now.
This study's enrollment of 166 is above the median of 129 across 975 interventional studies indexed under Pneumonia.
Browse Pneumonia studies →Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The first group consists of nine general practitioners having received a brief training on the use of ultrasound scanners in general practice. The general practitioner includes all adult patients who are consulting for one of the 8 medical conditions studied and perform an ultrasound scan. Two weeks later, he/she calls each patient to collect the necessary data.
Diagnostic Test: Ultrasound scan
The second group consists of nine general practitioners. Each physician includes all adult patients who are consulting for one of the 8 medical conditions studied and performs a standard consultation. Two weeks later, he/she calls each patient to collect the necessary data.
The group uses an ultrasound device for the consultation.
Number of complementary exams
Two weeks after the initial consultation, with or without ultrasound scanners, the general practitioners call their patients to know: * The number of imagery exams they had (ultrasound, MRI, scanner, radiology…) * The number of biological analysis (CRP, ASAT, ALAT, Lipase…)
Time frame: Two weeks after inclusion
Number of hospitalisations, specialist orientation or return home
Two weeks after the initial consultation, with or without ultrasound scanners, the general practitioners call their patients to know if within the past two weeks, they have been hospitalised, required emergency care, needed to consult a specialist, or returned back home
Time frame: Two weeks after inclusion
Cost of care
After knowing the patient orientation and the complementary exams they had, an estimation of the cost of care is made.
Time frame: Four weeks after inclusion in the study
Anxiety score measured by the State-Trait Anxiety Inventory (STAI-Y) scale
Two weeks after the initial consultation, with or without ultrasound scanners, the general practitioners call their patients to know the result of the anxiety test they took the day of the first consultation.
Time frame: Two weeks after inclusion in the study
Consultation duration
The day of the first consultation, the general practitioner writes the time spent
Time frame: Two weeks after inclusion in the study
Ran from Dec 2019 to primary completion in Oct 2021, 22 months.
Of 258 non-industry interventional studies with no phase under Pneumonia, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 31. This study's 22 months is close to that.
Counting every sponsor, half of 265 studies reached it within 21 months; a quarter within 10 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.